Access cutting-edge pulmonary fibrosis treatment through this clinical trial at a research site in New Haven. Study-provided care at no cost to qualified participants.
Access pulmonary fibrosis specialists in New Haven at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pulmonary fibrosis treatment provided free
This study is open to people with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF). They can only take part if they have completed treatment in a previous study with a medicine called nerandomilast or BI 1015550. The goal of this study is to find out how well people with pulmonary fibrosis tolerate long- term treatment with nerandomilast. The study also tests whether nerandomilast improves lung function and prolongs the time until symptoms get worse, participants need
Sponsor: Boehringer Ingelheim
Check if you qualify for this pulmonary fibrosis clinical trial in New Haven, CT
If you're searching for pulmonary fibrosis treatment options in New Haven, CT, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New Haven research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pulmonary fibrosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.